The landscape of medical weight management has been fundamentally transformed by a class of medications known as GLP-1 receptor agonists. Originally developed for type 2 diabetes, drugs like Semaglutide (marketed as Ozempic and Wegovy) and Tirzepatide (Mounjaro and Zepbound) have demonstrated remarkable efficacy in helping patients achieve significant, sustained weight loss when combined with lifestyle modifications.
How GLP-1 Medications Work
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone produced in your gut after eating. It signals your brain that you're full, slows gastric emptying, and helps regulate blood sugar. GLP-1 receptor agonists mimic this hormone at much higher concentrations, producing several beneficial effects:
- Appetite reduction — decreased hunger signals to the brain's satiety centers
- Slower gastric emptying — food stays in the stomach longer, promoting fullness
- Improved insulin sensitivity — better blood sugar regulation and reduced cravings
- Reduced food noise — patients report less obsessive thinking about food
Tirzepatide adds a second mechanism by also activating GIP (glucose-dependent insulinotropic polypeptide) receptors, which may explain its slightly greater efficacy in clinical trials.
Clinical Results: What the Research Shows
The STEP trials for Semaglutide demonstrated average weight loss of 15-17% of body weight over 68 weeks. The SURMOUNT trials for Tirzepatide showed even more impressive results, with patients losing up to 22.5% of body weight at the highest dose. These numbers represent a paradigm shift in obesity medicine — previously, only bariatric surgery could achieve comparable results.
Who Qualifies for GLP-1 Therapy?
At BKB Medical Center, we evaluate each patient individually. General criteria include:
- BMI of 30 or greater (obesity)
- BMI of 27 or greater with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia, sleep apnea)
- Previous unsuccessful attempts at weight loss through diet and exercise alone
- No contraindications (personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or pancreatitis)
Our Comprehensive Approach
At BKB Medical Center, we never prescribe GLP-1 medications in isolation. Our medical weight management program integrates these powerful tools within a comprehensive framework that includes metabolic evaluation with advanced lab work, personalized nutrition guidance, exercise recommendations tailored to your capacity, regular monitoring of side effects and progress, and dose titration optimized to your response.
Dr. Juan L. Brito Villalon, MD, oversees each patient's protocol, ensuring that medication therapy aligns with overall health goals and is adjusted based on lab results and clinical response.
Managing Side Effects
The most common side effects are gastrointestinal: nausea, constipation, and occasional diarrhea. These typically diminish over the first 4-8 weeks as your body adjusts. Our slow titration protocol minimizes these effects — we start at the lowest dose and increase gradually based on tolerance.
More serious but rare side effects include pancreatitis and gallbladder issues. Regular monitoring and open communication with your provider help identify any concerns early.
Beyond the Scale: Metabolic Benefits
GLP-1 medications offer benefits that extend far beyond weight loss. Clinical data shows improvements in cardiovascular risk markers, reduced systemic inflammation, improved fatty liver disease, better blood pressure control, and enhanced insulin sensitivity even before significant weight loss occurs.
Is GLP-1 Therapy Right for You?
If you've struggled with weight management despite genuine effort, GLP-1 therapy may be the missing piece. At BKB Medical Center, we begin with a thorough evaluation to determine if these medications are appropriate for your unique situation, health history, and goals.
Schedule a consultation to discuss whether medical weight management with GLP-1 therapy could help you achieve lasting results.
